Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment of clostridium difficile infection (CDI). It is also developing SER-155, a cultivated bacteria microbiome drug, which is Phase Ib clinical trial to reduce incidences of gastrointestinal infections, bloodstream infections, and graft versus host diseases in immunocompromised patients receiving allogeneic hematopoietic stem cell transplantation and solid organ transplants. In addition, the company engages in the development of SER-287 and SER-301 that are in Phase Ib to treat ulcerative colitis; SER-401 for patients with metastatic melanoma; and SER-262 to treat Clostridioides difficile infection. It has license and collaboration agreements with Nestec Ltd. and Memorial Sloan Kettering Cancer Center. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Seres Therapeutics Inc..
Seres Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Seres Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Seres Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Seres Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Seres Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Seres Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Seres Therapeutics Inc.- Key Facts
2.2 Seres Therapeutics Inc.- Geographic Locations
2.3 Seres Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Seres Therapeutics Inc.- Business Divisions
2.5 Seres Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Seres Therapeutics Inc. Strategic Analysis Review
3.1 Seres Therapeutics Inc.- Key Strategies
3.2 Seres Therapeutics Inc.- Company Outlook Statement
3.3 Seres Therapeutics Inc.- SWOT Analysis
3.3.1 Seres Therapeutics Inc.- Key Strengths
3.3.2 Seres Therapeutics Inc.- Key Weaknesses
3.3.3 Seres Therapeutics Inc.- Potential Opportunities
3.3.4 Seres Therapeutics Inc.- Potential Threats
3.4 Seres Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Seres Therapeutics Inc.- Business Overview
4.2 Seres Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Seres Therapeutics Inc.- Key Products
5.2 Seres Therapeutics Inc.- Key Service Areas
5.3 Seres Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Seres Therapeutics Inc.- Company History
6.2 Seres Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Seres Therapeutics Inc.- Income Statements
7.2 Seres Therapeutics Inc.- Balance Sheet
7.3 Seres Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Seres Therapeutics Inc.- Direct Competitors
8.2 Seres Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Seres Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Seres Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!